
Radiopharmaceuticals: Technologies and Global Markets
Description
Report Scope
This report analyzes the global market for radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers understand the market, to assess business/growth strategies, and to make informed business decisions regarding radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and 2024 and forecasts values for 2025 through 2029. The radiopharmaceuticals market segmentation is based on product, application, production method, countries and regions.
Drivers, restraints and opportunities in the radiopharmaceuticals market are also discussed. The report also describes the competitive landscape of the radiopharmaceuticals market and highlights emerging trends. The latest new products, acquisitions, and collaborations related to the radiopharmaceuticals market are also covered.
Report Includes
50 data tables and 68 additional tables
Analyses of trends in the global market for radiopharmaceuticals, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the size, and revenue prospects for, the global market, along with a market share analysis by product type, application, production method, and region/country
Facts and figures pertaining to the market dynamics, technological progress, regulations, prospects, innovations and the impact of various macroeconomic factors
Insights derived from the Porter’s Five Forces model, as well as global supply/value chain and PESTLE analyses
An analysis of patents, clinical trials, emerging trends and other developments in the industry
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of leading companies, including Cardinal Health, Lantheus, Curium, GE Healthcare, and Novartis AG
Companies Mentioned
BAYER AG
BLUE EARTH DIAGNOSTICS
BOSTON SCIENTIFIC CORP.
BWXT MEDICAL LTD.
CARDINAL HEALTH
CURIUM
ECKERT & ZIEGLER
GE HEALTHCARE
INTERNATIONAL ISOTOPES INC.
IONETIX CORP.
JUBILANT PHARMOVA LTD.
LANTHEUS
NMR
NOVARTIS AG
SIEMENS HEATHNIEERS AG
This report analyzes the global market for radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers understand the market, to assess business/growth strategies, and to make informed business decisions regarding radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and 2024 and forecasts values for 2025 through 2029. The radiopharmaceuticals market segmentation is based on product, application, production method, countries and regions.
Drivers, restraints and opportunities in the radiopharmaceuticals market are also discussed. The report also describes the competitive landscape of the radiopharmaceuticals market and highlights emerging trends. The latest new products, acquisitions, and collaborations related to the radiopharmaceuticals market are also covered.
Report Includes
50 data tables and 68 additional tables
Analyses of trends in the global market for radiopharmaceuticals, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the size, and revenue prospects for, the global market, along with a market share analysis by product type, application, production method, and region/country
Facts and figures pertaining to the market dynamics, technological progress, regulations, prospects, innovations and the impact of various macroeconomic factors
Insights derived from the Porter’s Five Forces model, as well as global supply/value chain and PESTLE analyses
An analysis of patents, clinical trials, emerging trends and other developments in the industry
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of leading companies, including Cardinal Health, Lantheus, Curium, GE Healthcare, and Novartis AG
Companies Mentioned
BAYER AG
BLUE EARTH DIAGNOSTICS
BOSTON SCIENTIFIC CORP.
BWXT MEDICAL LTD.
CARDINAL HEALTH
CURIUM
ECKERT & ZIEGLER
GE HEALTHCARE
INTERNATIONAL ISOTOPES INC.
IONETIX CORP.
JUBILANT PHARMOVA LTD.
LANTHEUS
NMR
NOVARTIS AG
SIEMENS HEATHNIEERS AG
Table of Contents
163 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope Of Report
- Market Summary
- Chapter 2 Market Overview
- Radiopharmaceuticals Overview
- Preparation Of Radiopharmaceuticals
- Macroeconomic Factors Analysis
- Porter’s Five Forces Analysis
- Threat Of New Entrants (Moderate To Low)
- Threat Of Substitutes (Low To Moderate)
- Bargaining Power Of Suppliers (High)
- Bargaining Power Of Buyers (Moderate)
- Industry Rivalry (Moderate)
- Chapter 3 Market Dynamics
- Market Drivers
- Rising Prevalence Of Cancer And Other Chronic Diseases
- Unmet Need In Oncology
- Precision Medicine
- Nuclear Imaging Technologies
- Increasing Investment
- Market Restraints
- Manufacturing And Supply Chain Issues
- Infrastructure And Specialized Imaging Equipment Requirements
- Shortage Of Skilled Professionals
- Market Trends
- Theranostics
- Regional Diversification And Supply Chain Resilience
- Opportunities
- Radiopharmaceuticals Contract Manufacturing
- Pet Imaging In Ad
- Chapter 4 Regulatory Landscape
- U.S.
- European Union
- Japan
- Chapter 5 Emerging Technologies And Developments
- Emerging Technologies
- Ac-225 And Pb-212
- Nanoparticle-based Theranostic Agents
- Clinical Trials Analysis
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Patent Analysis
- Key Takeaways
- Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Radiopharmaceuticals Market, By Product Type
- Diagnostic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals Market, By Imaging Technique Type
- Diagnostic Radiopharmaceuticals Market, By Production Method
- Therapeutic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals Market, By Product Type
- Radiopharmaceuticals Market By Application
- Market Overview
- Oncology
- Cardiology
- Neurology
- Others
- Radiopharmaceuticals Market By Radioisotope Production Method
- Market Overview
- Market Revenue And Forecast
- Geographic Breakdown
- Radiopharmaceuticals Market Breakdown By Region
- North America
- Europe
- Asia-pacific
- Row
- Chapter 7 Competitive Intelligence
- Overview
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Chapter 8 Sustainability In Radiopharmaceuticals Market: Esg Perspective
- Role Of Esg In The Radiopharmaceuticals Industry
- Environment
- Social
- Governance
- Esg Risk Ratings
- Conclusion
- Chapter 9 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- Bayer Ag
- Blue Earth Diagnostics
- Boston Scientific Corp.
- Bwxt Medical Ltd.
- Cardinal Health
- Curium
- Eckert & Ziegler
- Ge Healthcare
- International Isotopes Inc.
- Ionetix Corp.
- Jubilant Pharmova Ltd.
- Lantheus
- Nmr
- Novartis Ag
- Siemens Heathnieers Ag
- Emerging Start-ups/Market Disruptors
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.